ELEVANCE HEALTH INC (ELV) Stock Institutional Trading Activity


ELEVANCE HEALTH INC (ELV) position changes reported by tracked institutional filers across multiple SEC 13F reporting periods. Based on recent SEC 13F filings (Q4 2025), investors with some of the largest reported share count changes include Brave Warrior Advisors, Eagle Capital Management, Baupost Group, Vulcan Value Partners, and Yacktman Asset Management. Explore insights into buying and selling patterns, position changes, and investment conviction levels to understand institutional trading behavior and market dynamics.

Explore more:

Portfolio quarterNameTypeQuantityRemainingReported stock balance
Q2 2018Vulcan Value PartnersSell-667,468636,193$151,433
Q2 2018First Eagle U.S. ValueBuy92,7193,041,254$723,910
Q2 2018Viking Global InvestorsBuy25,2224,454,770$1,060,369
Q1 2018Dodge & Cox Stock FundSell-8001,400$308
Q1 2018Yacktman Asset ManagementSell-9,039826,673$181,620
Q1 2018Renaissance Technologies LLCSell-38,327633,273$139,130
Q1 2018Third PointBuy410,000785,000$172,464
Q1 2018Vulcan Value PartnersSell-23,6221,303,661$286,414
Q1 2018First Eagle U.S. ValueSell-194,9652,948,535$647,793
Q1 2018Viking Global InvestorsBuy1,891,9724,429,548$973,172
Q4 2017Gardner Russo & QuinnBuy100100$23
Q4 2017Yacktman Asset ManagementSell-186,791835,712$188,044
Q4 2017Third PointSell-875,000375,000$84,379
Q4 2017Renaissance Technologies LLCSell-498,373671,600$151,117
Q4 2017Vulcan Value PartnersBuy454,8921,327,283$298,652
Q4 2017Viking Global InvestorsBuy1,664,1122,537,576$570,980
Q4 2017First Eagle U.S. ValueBuy39,6083,143,500$707,319
Q3 2017Dodge & Cox Stock FundSell-64,1502,200$418
Q3 2017Parnassus Endeavor FundSell-200,000400,000$75,952
Q3 2017Yacktman Asset ManagementSell-5,9891,022,503$194,153
Q3 2017Vulcan Value PartnersSell-817,225872,391$165,649
Q3 2017Viking Global InvestorsBuy586,784873,464$165,853
Q3 2017Renaissance Technologies LLCBuy302,7731,169,973$222,154
Q3 2017First Eagle U.S. ValueBuy71,1193,103,892$589,367
Q2 2017Dodge & Cox Stock FundSell-2,773,01866,350$12,482
Q2 2017Yacktman Asset ManagementSell-5,9451,028,492$193,490
Q2 2017Viking Global InvestorsSell-4,562,549286,680$53,933
Q2 2017Renaissance Technologies LLCSell-368,400867,200$163,146
Q2 2017Third PointBuy100,0001,250,000$235,162
Q2 2017Vulcan Value PartnersSell-41,1341,689,616$317,867

Frequently asked questions about ELV activity

  • Which institutional owners are buying ELV?

    Institutional owners buying ELV include investors who have either initiated new positions or increased their existing holdings based on recent SEC 13F filings. The activity table above highlights which funds added shares in the latest reporting periods and how their positions changed over time.

  • What does "buy" mean in ELV activity?

    "Buy" means an investor increased their reported position in ELV compared to the prior reporting period. This reflects growing exposure to ELEVANCE HEALTH INC (ELV) rather than necessarily a brand-new position (though new positions also appear as buys when prior quantity was zero).

  • Is institutional interest in ELV increasing?

    Institutional interest in ELV can be assessed by comparing the number of tracked funds adding or increasing positions versus those trimming or exiting across the periods shown. A higher number of additions typically signals increasing participation among large filers, but it should be read alongside position sizes and the full table.